Tremor News and Research

Latest Tremor News and Research

Study characterizes effects of opioids on brain proteins other than opioid receptors

In a new study, researchers have characterized the effects of a series of opioids on proteins in the brain other than opioid receptors.

6 Dec 2017

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

In its latest pioneering effort to harness the power of focused ultrasound to battle disease, the University of Virginia Health System is examining the scalpel-free surgery's potential to enable the body to identify and destroy metastatic breast cancer cells.

8 Nov 2017

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

DGIST's research team led by Dr. Yun-Il Lee in Well-Aging Research Center has identified a new mechanism of inhibition of dopaminergic neuronal apoptosis and suggested the possibility of preventing and treating Parkinson's disease.

8 Nov 2017

OHSU study shows better clinical outcomes for deep brain stimulation while patients are asleep

Deep brain stimulation is a long-established surgical procedure that eases the effects of Parkinson's disease and essential tremor through pulses from tiny electrodes implanted in the brain. Currently, most surgeons around the world conduct this surgery while the patient is awake.

3 Nov 2017

Pilot study: Focused ultrasound shows potential for managing Parkinson's tremor

An initial test to determine if a scalpel-free form of brain surgery can reduce tremor caused by Parkinson's disease has produced encouraging results. Further research is warranted, the researchers conclude in a paper published today by the scientific journal JAMA Neurology.

30 Oct 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Myelin sheaths restore impaired nervous system over the long haul

In the central nervous system of humans and all other mammals, a vital insulating sheath composed of lipids and proteins around nerve fibers helps speed the electrical signals or nerve impulses that direct our bodies to walk, talk, breathe, swallow or perform any routine physical act.

24 Oct 2017

NTU Singapore, KAIST scientists discover new mechanism that causes Parkinsonian symptoms

Scientists from Nanyang Technological University, Singapore and the Korea Advanced Institute of Science & Technology have identified a new mechanism that causes the hallmark symptoms of Parkinson's disease, namely tremors, rigidity, and loss of voluntary movement.

28 Sep 2017

Researchers identify new mechanism that causes hallmark symptoms of Parkinson's disease

A KAIST research team has identified a new mechanism that causes the hallmark symptoms of Parkinson's disease, namely tremors, rigidity, and loss of voluntary movement.

26 Sep 2017

Reprogrammed stem cell therapy shows promise in Parkinson's

Japanese investigators have found that their experimental stem cell therapy for Parkinson’s disease actually works. In their experimental therapy, the team of researchers “reprogrammed” stem cells to make them neurons and implanted them into the brain of monkeys with a version of Parkinson’s disease. Stem cell therapy showed improvement of symptoms in these patients and was found to be safe. The study was published yesterday, 30th August 2017 in Nature.

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

MR-guided focused ultrasound continues to gain momentum in treating essential tremor patients

INSIGHTEC announced today that worldwide adoption of MR-guided focused ultrasound continues to gain momentum as Exablate Neuro patient treatment numbers surpass the 1000 mark.

18 Aug 2017

Smartphone-based biofeedback rehabilitation system aims to improve balance in Parkinson's patients

University of Houston researchers in the Department of Health and Human Performance are helping patients with Parkinson's disease regain stable balance and confidence in performing daily activities in their own homes.

31 Jul 2017

Mayo Clinic study provides information on survival and death of patients with synucleinopathies

Faced with a serious disease, patients want to know the answer to a difficult question: "How long will I live?"

16 May 2017

Use of stimulants may lead to psychomotor control deficits, study finds

Researchers have found that current or past use of methamphetamine or other stimulants may lead to psychomotor control deficits, or a reduced ability to control physical movement.

20 Apr 2017

Rat study reveals new clues to devastating neurological disease

After a 29-year quest, Ian Duncan, a professor of veterinary medicine at the University of Wisconsin-Madison, has finally pinpointed the cause of a serious neurologic disease in a colony of rats.

20 Apr 2017

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

A surgical technique that sends electrical impulses to a specific area of the brain reduces the "tics," or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to a new study led by investigators from NYU Langone Medical Center.

7 Apr 2017

UC researchers advocate ‘precision medicine’ approach to studying and treating Parkinson's disease

Two landmark publications with one or more co-authors from the University of Cincinnati Gardner Neuroscience Institute outline a transformative approach to defining, studying and treating Parkinson's disease.

22 Mar 2017

SPECT imaging may not be suitable for monitoring Parkinson's disease, study shows

When monitoring Parkinson's disease, SPECT imaging of the brain is used for acquiring information on the dopamine activity. A new study conducted in Turku, Finland, shows that the dopamine activity observed in SPECT imaging does not reflect the number of dopamine neurons in the substantia nigra, as previously assumed.

22 Mar 2017

FDA approves drug as add-on treatment for Parkinson's disease patients

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson's disease who are currently taking levodopa/carbidopa and experiencing "off" episodes.

21 Mar 2017

Tremor News and Research

Latest Tremor News and Research

Study characterizes effects of opioids on brain proteins other than opioid receptors

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

OHSU study shows better clinical outcomes for deep brain stimulation while patients are asleep

Pilot study: Focused ultrasound shows potential for managing Parkinson's tremor

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Myelin sheaths restore impaired nervous system over the long haul

NTU Singapore, KAIST scientists discover new mechanism that causes Parkinsonian symptoms

Researchers identify new mechanism that causes hallmark symptoms of Parkinson's disease

Reprogrammed stem cell therapy shows promise in Parkinson's

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

MR-guided focused ultrasound continues to gain momentum in treating essential tremor patients

Smartphone-based biofeedback rehabilitation system aims to improve balance in Parkinson's patients

Mayo Clinic study provides information on survival and death of patients with synucleinopathies

Use of stimulants may lead to psychomotor control deficits, study finds

Rat study reveals new clues to devastating neurological disease

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

UC researchers advocate ‘precision medicine’ approach to studying and treating Parkinson's disease

SPECT imaging may not be suitable for monitoring Parkinson's disease, study shows

FDA approves drug as add-on treatment for Parkinson's disease patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Tremor News and Research

Latest Tremor News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in